Skip to main content
创远信科 logo

创远信科 — Investor Relations & Filings

Ticker · 920961 Beijing Stock Exchange Manufacturing
Filings indexed 657 across all filing types
Latest filing 2024-12-17 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920961

About 创远信科

https://www.transcom.net.cn/

Transcom Instruments specializes in the research, development, and manufacturing of high-end wireless communication testing and measurement equipment. The company provides a comprehensive suite of solutions including vector network analyzers, signal generators, spectrum analyzers, and wireless network optimization tools. Its product portfolio serves critical sectors such as telecommunications, aerospace, defense, and automotive electronics. Transcom is recognized for its expertise in RF and microwave technology, offering advanced testing capabilities for 5G and emerging 6G standards. By focusing on independent innovation, the company delivers high-precision instruments and integrated testing systems designed to ensure the reliability and performance of wireless infrastructure and mobile devices.

Recent filings

Filing Released Lang Actions
关于收到政府补助的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (507 characters) regarding the receipt of government subsidies by the company. It includes a statement about the accounting treatment of the subsidy according to accounting standards and mentions that the final accounting treatment will be confirmed by the annual audit. There is no detailed financial data, no full report, and no mention of a specific report being attached or published. The document is an update on a financing-related event (government subsidy receipt), which fits best under Capital/Financing Update (CAP). It is not an annual report, audit report, or regulatory filing. Given the short length and content, CAP is the most appropriate classification.
2024-12-17 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is an investor relations activity record from 创远信科 (Chuangyuan Xinke), detailing a specific investor meeting held on December 13, 2024. It includes questions and answers about the company's R&D, competitive advantages, intellectual property strategy, product sales, future business growth, and potential M&A plans. The document is a record of a specific investor relations event rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. The document length is 3045 characters, which is relatively short and focused on investor relations activities. Therefore, it fits best into the category of Investor Presentation (IP) or a similar category related to investor communications. However, since it is a record of an investor relations activity (a Q&A session), it aligns most closely with Investor Presentation (IP) rather than a formal earnings release or annual report. Hence, the classification is Investor Presentation (IP).
2024-12-15 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is an investor relations activity record from 创远信科 (Chuangyuan Xinke), detailing a specific investor relations event held on December 10, 2024. It includes questions and answers about company strategy, government policy impact, business progress, cooperation with universities, headquarters construction, and shareholder return plans such as share repurchases and dividends. The document is a record of a specific investor relations meeting rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. It is not a transcript of a conference call but a summary of an investor relations event. Therefore, the document best fits the category of Investor Presentation (IP), as it provides detailed information for investors focusing on company strategy, business updates, and market position.
2024-12-10 Chinese
关于取得美国专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of two US patent certificates. It includes details about the patents, their numbers, and the impact on the company. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is short (1124 characters) and is an announcement of a corporate event related to intellectual property. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a corporate development. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-09 Chinese
关于收到政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (494 characters) about the company receiving government subsidies, including the amount and the accounting treatment to be applied. It does not contain financial statements or detailed financial analysis. It is not a full report but a regulatory announcement informing investors about the subsidy and its accounting treatment. The document length and content indicate it is not a financial report but a regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-12-02 Chinese
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is an investor relations activity record from a company, detailing a specific investor meeting held on November 26, 2024. It includes questions and answers about the company's products, market activities, financial performance (like gross margin), and future plans. There are no financial statements, no audit opinions, no regulatory certifications, no voting results, no merger or acquisition details, and no announcement of a report publication. The content is a detailed record of an investor relations event, which is not a financial report or regulatory filing but a communication with investors. This fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement and investor relations disclosure that does not fit other specific categories.
2024-11-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.